SRRA - Sierra Oncology EPS misses by $0.06 August, 05 2021 05:40 PM Sierra Oncology Inc. Sierra Oncology (NASDAQ:SRRA): Q2 Non-GAAP EPS of -$1.41; GAAP EPS of -$1.67 misses by $0.06. Cash and cash equivalents of $90.7M Press Release For further details see: Sierra Oncology EPS misses by $0.06